Acta Metallurgica Sinica.
Abstract:Polycystic ovary syndrome (PCOS) is a common metabolic dysfunction and heterogeneous endocrine disorder in women of reproductive age.PCOS is characterized by a clustering of hyperandrogenism, hyperinsulinemia, hypersecretion of LH, menstrual dysfunction, hirsutism, infertility and pregnancy and neonatal complications. PCOS also contributes to other long-term health risks, metabolic complications and psychological problems, such as type II diabetes mellitus (DM2), cardiovascular disease (CVD), poor self-esteem, venous thromboembolism (VTE) and anxiety. In addition, a wide range in the incidence of PCOS has been reported in small samples from different countries. As a result, most studies quoted a prevalence of PCOS ranging from 5% to 10%. However, previous reports from a variety of different countries demonstrate the diversity in the incidence of PCOS, and the prevalence of PCOS also depends on the criteria used to evaluate this syndrome. Different PCOS prevalence surveys have been carried out in specific populations using special diagnostic criteria.